vs
HORIZON BANCORP INC（HBNC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是HORIZON BANCORP INC的1.2倍（$75.5M vs $63.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 19.5%），HORIZON BANCORP INC自由现金流更多（$74.3M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 9.2%）
第一地平线集团（原第一田纳西银行）是一家金融服务企业，1864年成立，总部位于美国田纳西州孟菲斯。集团通过旗下银行子公司第一地平线银行，在美国东南部12个州开展金融业务，是该区域第四大区域性银行。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HBNC vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$63.5M
营收增速更快
PBYI
高出8.2%
19.5%
自由现金流更多
HBNC
多$59.9M
$14.4M
两年增速更快
PBYI
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $75.5M |
| 净利润 | $26.9M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 51.5% | 22.7% |
| 净利率 | 42.4% | — |
| 营收同比 | 19.5% | 27.7% |
| 净利润同比 | 347.4% | — |
| 每股收益（稀释后） | $0.44 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HBNCPBYI
| Q4 25 | $63.5M | $75.5M | ||
| Q3 25 | $58.4M | $54.5M | ||
| Q2 25 | $66.3M | $52.4M | ||
| Q1 25 | $68.8M | $46.0M | ||
| Q4 24 | $53.1M | $59.1M | ||
| Q3 24 | $58.4M | $80.5M | ||
| Q2 24 | $55.8M | $47.1M | ||
| Q1 24 | $53.2M | $43.8M |
净利润HBNCPBYI
| Q4 25 | $26.9M | — | ||
| Q3 25 | $-222.0M | $8.8M | ||
| Q2 25 | $20.6M | $5.9M | ||
| Q1 25 | $23.9M | $3.0M | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $18.2M | $20.3M | ||
| Q2 24 | $14.1M | $-4.5M | ||
| Q1 24 | $14.0M | $-4.8M |
毛利率HBNCPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率HBNCPBYI
| Q4 25 | 51.5% | 22.7% | ||
| Q3 25 | -490.4% | 17.6% | ||
| Q2 25 | 36.8% | 12.7% | ||
| Q1 25 | 40.8% | 8.7% | ||
| Q4 24 | -41.3% | 22.6% | ||
| Q3 24 | 31.0% | 27.4% | ||
| Q2 24 | 28.5% | -4.6% | ||
| Q1 24 | 28.8% | -5.3% |
净利率HBNCPBYI
| Q4 25 | 42.4% | — | ||
| Q3 25 | -380.2% | 16.2% | ||
| Q2 25 | 31.1% | 11.2% | ||
| Q1 25 | 34.8% | 6.5% | ||
| Q4 24 | -20.5% | — | ||
| Q3 24 | 31.1% | 25.2% | ||
| Q2 24 | 25.4% | -9.6% | ||
| Q1 24 | 26.3% | -11.0% |
每股收益（稀释后）HBNCPBYI
| Q4 25 | $0.44 | $0.26 | ||
| Q3 25 | $-4.69 | $0.17 | ||
| Q2 25 | $0.47 | $0.12 | ||
| Q1 25 | $0.54 | $0.06 | ||
| Q4 24 | $-0.25 | $0.40 | ||
| Q3 24 | $0.41 | $0.41 | ||
| Q2 24 | $0.32 | $-0.09 | ||
| Q1 24 | $0.32 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $139.5M | $97.5M |
| 总债务越低越好 | $248.6M | $22.7M |
| 股东权益账面价值 | $688.3M | $130.3M |
| 总资产 | $6.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.36× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HBNCPBYI
| Q4 25 | $139.5M | $97.5M | ||
| Q3 25 | $458.3M | $94.4M | ||
| Q2 25 | $137.9M | $96.0M | ||
| Q1 25 | $169.7M | $93.2M | ||
| Q4 24 | $293.4M | $101.0M | ||
| Q3 24 | $234.8M | $96.7M | ||
| Q2 24 | $146.1M | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务HBNCPBYI
| Q4 25 | $248.6M | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $1.2B | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HBNCPBYI
| Q4 25 | $688.3M | $130.3M | ||
| Q3 25 | $660.8M | $115.3M | ||
| Q2 25 | $790.9M | $104.7M | ||
| Q1 25 | $776.1M | $97.1M | ||
| Q4 24 | $763.6M | $92.1M | ||
| Q3 24 | $754.8M | $71.1M | ||
| Q2 24 | $726.7M | $48.5M | ||
| Q1 24 | $721.3M | $51.0M |
总资产HBNCPBYI
| Q4 25 | $6.4B | $216.3M | ||
| Q3 25 | $6.7B | $202.9M | ||
| Q2 25 | $7.7B | $194.9M | ||
| Q1 25 | $7.6B | $196.2M | ||
| Q4 24 | $7.8B | $213.3M | ||
| Q3 24 | $7.9B | $220.7M | ||
| Q2 24 | $7.9B | $205.0M | ||
| Q1 24 | $7.9B | $214.1M |
负债/权益比HBNCPBYI
| Q4 25 | 0.36× | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 1.61× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $79.2M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $74.3M | $14.4M |
| 自由现金流率自由现金流/营收 | 117.0% | 19.1% |
| 资本支出强度资本支出/营收 | 7.8% | 0.0% |
| 现金转化率经营现金流/净利润 | 2.94× | — |
| 过去12个月自由现金流最近4个季度 | $115.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HBNCPBYI
| Q4 25 | $79.2M | $14.4M | ||
| Q3 25 | $10.9M | $9.7M | ||
| Q2 25 | $19.5M | $14.1M | ||
| Q1 25 | $15.2M | $3.6M | ||
| Q4 24 | $6.4M | $15.6M | ||
| Q3 24 | $32.3M | $11.0M | ||
| Q2 24 | $15.9M | $1.0M | ||
| Q1 24 | $6.5M | $11.2M |
自由现金流HBNCPBYI
| Q4 25 | $74.3M | $14.4M | ||
| Q3 25 | $9.4M | $9.7M | ||
| Q2 25 | $18.1M | $14.1M | ||
| Q1 25 | $14.1M | $3.6M | ||
| Q4 24 | $1.3M | $15.6M | ||
| Q3 24 | $31.0M | $11.0M | ||
| Q2 24 | $15.1M | $1.0M | ||
| Q1 24 | $5.4M | — |
自由现金流率HBNCPBYI
| Q4 25 | 117.0% | 19.1% | ||
| Q3 25 | 16.1% | 17.7% | ||
| Q2 25 | 27.3% | 26.8% | ||
| Q1 25 | 20.5% | 7.7% | ||
| Q4 24 | 2.4% | 26.4% | ||
| Q3 24 | 53.1% | 13.7% | ||
| Q2 24 | 27.1% | 2.1% | ||
| Q1 24 | 10.1% | — |
资本支出强度HBNCPBYI
| Q4 25 | 7.8% | 0.0% | ||
| Q3 25 | 2.6% | 0.0% | ||
| Q2 25 | 2.1% | 0.0% | ||
| Q1 25 | 1.6% | 0.1% | ||
| Q4 24 | 9.6% | 0.0% | ||
| Q3 24 | 2.2% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 2.2% | 0.0% |
现金转化率HBNCPBYI
| Q4 25 | 2.94× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | 0.94× | 2.41× | ||
| Q1 25 | 0.64× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.78× | 0.54× | ||
| Q2 24 | 1.13× | — | ||
| Q1 24 | 0.47× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
